Acute management

The European Single Hub and Access point for paediatric Rheumatology in Europe initiative aimed to optimize care for children with rheumatic diseases. Kawasaki Disease is the most common cause of acquired heart disease in children and an important cause of long-term cardiac disease into adulthood. Prompt diagnosis and treatment of Kawasaki Disease is difficult due […]

A Japanese paper describing the use of CCTA to support Kawasaki Disease diagnosis.

Predictors of intravenous immunoglobulin-resistant Kawasaki disease

Every clinician needs a high index of suspicion. This paper contains new information to enhance it.

‘When you hear hoofbeats, think of horses not zebras’ – the old adage is well-known to GPs but what should you do when faced with a zebra, not a horse?

Incomplete Kawasaki Disease in the Neonate – Case report of Kawasaki Disease in a 15 DAY old boy.

This paper looks at scoring methods to predict responses to IVIG therapy in a Caucasian population

Diagnosis and management of Kawasaki Disease in developing countries

This study suggests that corticosteroids combined with IVIG as initial therapy for KD showed a more protective effect against CAA, compared with conventional IVIG therapy, and the efficacy was more pronounced in the high-risk patient group.

A discussion paper on Kawasaki Disease which concludes that many aspects of KD remain unknown, although there is growing knowledge on the etiology